(Q51299240)

3 April 2018

title

Prevalence of cardiovascular diseases in HIV-infected outpatients: results from a prospective, multicenter cohort study. (English)

1 reference

3 April 2018

main subject

cardiovascular disease

1 reference

5

Dirk Schadendorf

1 reference

3 April 2018

6

Raimund Erbel

1 reference

3 April 2018

author name string

Stefan Esser

1

1 reference

3 April 2018

Götz Gelbrich

2

1 reference

3 April 2018

Norbert Brockmeyer

3

1 reference

3 April 2018

Alexander Goehler

4

1 reference

3 April 2018

Till Neumann

7

1 reference

3 April 2018

Nico Reinsch

8

1 reference

3 April 2018

publication date

2 November 2012

1 reference

3 April 2018

Clinical Research in Cardiology

published in

1 reference

3 April 2018

volume

102

1 reference

3 April 2018

issue

3

1 reference

3 April 2018

page(s)

203-213

1 reference

3 April 2018

https://scigraph.springernature.com/pub.10.1007/s00392-012-0519-0

exact match

0 references

cites work

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0519-0

Combination antiretroviral therapy and the risk of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0519-0

Contribution of the human immunodeficiency virus/acquired immunodeficiency syndrome epidemic to de novo presentations of heart disease in the Heart of Soweto Study cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0519-0

Metabolic complications associated with antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0519-0

Targeted myocardial transgenic expression of HIV Tat causes cardiomyopathy and mitochondrial damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0519-0

Biomarkers and HIV-associated cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0519-0

General cardiovascular risk profile for use in primary care: the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0519-0

Cardiovascular manifestations in human immunodeficiency virus-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0519-0

Cardiac manifestations of HIV infection: an African perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0519-0

Epidemiological evidence for cardiovascular disease in HIV-infected patients and relationship to highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0519-0

Cerebrovascular ischemic events in HIV-1-infected patients receiving highly active antiretroviral therapy: incidence and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0519-0

Class of Antiretroviral Drugs and the Risk of Myocardial Infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0519-0

Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0519-0

Comparisons of causes of death and mortality rates among HIV-infected persons: analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0519-0

CD4+ count-guided interruption of antiretroviral treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0519-0

Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0519-0

Coronary risk stratification, discrimination, and reclassification improvement based on quantification of subclinical coronary atherosclerosis: the Heinz Nixdorf Recall study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0519-0

Heart-focused anxiety in the general population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0519-0

Cardiological evaluation after cerebral ischaemia : Consensus statement of the Working Group Heart and Brain of the German Cardiac Society-Cardiovascular Research (DGK) and the German Stroke Society (DSG).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0519-0

A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0519-0

Initiation of antiretroviral therapy at higher nadir CD4+ T-cell counts is associated with reduced arterial stiffness in HIV-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0519-0

Metabolic and immune activation effects of treatment interruption in chronic HIV-1 infection: implications for cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0519-0

Cardio- and cerebrovascular events in HIV-infected persons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0519-0

Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0519-0

What a cardiologist needs to know about patients with human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0519-0

HIV viral protein R causes atrial cardiomyocyte mitosis, mesenchymal tumor, dysrhythmia, and heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0519-0

Prevalence of cardiac diastolic dysfunction in HIV-infected patients: results of the HIV-HEART study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0519-0

Cardiovascular risk estimation in 2012: lessons learned and applicability to the HIV population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0519-0

Ischemic Heart Disease in HIV-Infected and HIV-Uninfected Individuals: A Population-Based Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0519-0

Protease inhibitor exposure and increased risk of cardiovascular disease in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0519-0

Guidelines for the Evaluation and Management of Dyslipidemia in Human Immunodeficiency Virus (HIV)-Infected Adults Receiving Antiretroviral Therapy: Recommendations of the HIV Medicine Association of the Infectious Disease Society of America and the

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-012-0519-0

Cardiomyopathy with mitochondrial damage associated with nucleoside reverse-transcriptase inhibitors

21 January 2018

1 reference

12 December 2020

HIV gp120 enhances NO production by cardiac myocytes through p38 MAP kinase-mediated NF-kappaB activation

1 reference

12 December 2020

Updated antiretroviral treatment guidelines from DHHS and EACS

1 reference

12 December 2020

Cardiovascular manifestations of HIV infection

1 reference

12 December 2020

Prevalence and natural history of heart failure in outpatient HIV-infected subjects: rationale and design of the HIV-HEART study.

1 reference

12 December 2020

Management of metabolic complications and cardiovascular risk in HIV-infected patients

1 reference

12 December 2020

QT interval prolongation and antiretroviral treatment: another point of interest

1 reference

12 December 2020

Are HIV patients undertreated? Cardiovascular risk factors in HIV: results of the HIV-HEART study

1 reference

12 December 2020

Cardiovascular risk factors and probability for cardiovascular events in HIV-infected patients - part III: age differences.

1 reference

12 December 2020

Low prevalence of cardiac abnormalities in an HIV-seropositive population on antiretroviral combination therapy

1 reference

12 December 2020

Dilated cardiomyopathy in two adult human immunodeficiency positive (HIV+) patients possibly related to highly active antiretroviral therapy (HAART)

1 reference

12 December 2020

10.1007/S00392-012-0519-0

Identifiers

DOI

1 reference

3 April 2018

PubMed ID

23117698

1 reference

3 April 2018